Sensidose AB is a pharmaceutical company that has developed an innovative new system for individualized dosing of pharmaceutical tablets, allowing for optimized drug therapy.
The system is composed of “micro”- tablets, sub-pharmaceutical units of tablets. The correct dose is achieved by dosing a certain number of tablets. The “micro”- tablets are retrieved using an automated dispenser. The dispenser has an inbuilt alarm, delivers doses at the programmed time point, and registers all doses delivered as well as disease symptoms with the help of easy to use scales.
The company’s technology is expected to have the potential to reduce side effects and contribute to increased quality of life for the patient